Skip to main content
. 2010 Jul;30(7):461–464. doi: 10.1089/jir.2009.0090

Table 1.

Change in HIV RNA and CD4+ T-Lymphocyte Count

  AZT (N = 58) IFN-α (N = 54)a AZT+IFN-α (N = 54)a P valueb
Virologic
 Baseline log viral load (copies/mL) 3.51 ± 0.09 3.57 ± 0.11 3.66 ± 0.11 0.56
 Time to last viral load visit (weeks) 47.5 ± 0.5 44.9 ± 1.7 45.2 ± 1.3 0.20
 Difference in log HIV RNA (copies/mL) −0.06 ± 0.06 −0.35 ± 0.09 −0.47 ± 0.12 0.01
 Standardized area under curve for log HIV RNA −0.02 ± 0.01 −0.27 ± 0.02 −0.41 ± 0.02 0.0001
 % Baseline HIV RNA <50 (copies/mL) 1.7% 3.9% 1.9% 0.75
 % Last HIV RNA <50 (copies/mL) 3.5% 13.5% 13.5% 0.09
Immunologic
 Baseline CD4 count
  Absolute 744 ± 27 686 ± 23 790 ± 35 0.08
  Percentage 37.3 ± 1.0 37.1 ± 1.3 38.1 ± 1.2 0.46
  Time to last CD4 count (weeks) 47.3 ± 0.5 44.4 ± 1.5 45.6 ± 1.1 0.77
 Change in CD4 count
  Absolute −40 ± 22 −102 ± 24 −97 ± 28 0.13
  Percentage 0.6 ± 0.6 −1.5 ± 1.0 −1.1 ± 0.7 0.18

Values for continuous variables are expressed as mean ± standard error, and are expressed as percentages for binary variables.

a

N = 52 in viral load analysis.

b

P values for comparing continuous variables are derived by using the Kruskal–Wallis test and P values for comparing binary variables are derived by using the χ2-test; P values <0.05 represent a significant difference among the 3 groups.

Abbreviations: AZT, zidovudine; IFN-α, interferon-α.